Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Z006889 | SC / LA |
Moderate to severe erythema, swelling, warmth at injection site and surrounding area that began 1 day after injection. Resolved with symptomatic treatment (ice, NSAIDS, range of motion exercises).
None
CML in remission x several years
Sprycell, metoprolol
Lamisil
No additional testing. Physical exam only.